The SPARSH platform’s first version features ECG sensing, with plans to add PPG, BioZ and skin temperature monitoring capabilities
Sophrosyne Technologies has unveiled the first version of its indigenous biomedical sensor chipset under its SPARSH platform for wearable health monitoring at the Bengaluru Tech Summit. The development marks a step towards developing semiconductor technologies in India for healthcare applications.
The unveiling took place under the Beyond Bengaluru initiative during a session chaired by officials from the Karnataka Digital Economy Mission (KDEM) and the Department of Electronics, IT, Biotechnology and Science & Technology, Government of Karnataka.
The company presented lab-validated silicon samples featuring Electrocardiogram (ECG) sensing capabilities, demonstrating the chipset’s potential for use in wearable health monitoring devices.
Sophrosyne is developing a commercial-grade version of the chipset, with plans to incorporate additional sensing capabilities, including Photoplethysmography (PPG), Bioimpedance (BioZ) and skin temperature monitoring. The platform is designed around an ultra-low-power architecture and high-precision biosignal acquisition to support compact, energy-efficient health monitoring solutions.
The company is also engaging with wearable technology brands across India and Europe to explore integration opportunities in smartwatches, fitness bands, smart rings and cardiac monitoring patches.
Through SPARSH, Sophrosyne aims to contribute to India’s indigenous semiconductor ecosystem and enable the development of wearable healthcare technologies.